Adaptive Immunity  by unknown
Adaptive Immunity  | ABSTRACTS
www.jidonline.org   S1
001Adaptive Immunity 
Calcitonin gene-related peptide (CGRP) biases Langerhans cell (LC) antigen presentation 
towards a Th17 response through actions on endothelial cells
RD Granstein, LL Stohl, M Manni, JA Wagner and W Ding Weill Cornell Medical College, 
New York, NY
We have previously demonstrated that exposure of the transformed, brain-derived murine endo-
thelial cell (EC) line bEnd.3 to CGRP biases the result of antigen presentation toward an IL-17A 
response. We have now asked whether CGRP induces primary murine dermal microvascular ECs to 
bias LC antigen presentation to CD4+ T cells towards differentiation of Th17 cells. Primary BALB/c 
dermal microvascular ECs (1 x 104/well) were plated in round bottom 96-well plates in 200 μl of 
medium containing 100 nM CGRP. After 3 h, plates were washed x 4. Then, 1 x 104 BALB/c LCs 
and 2 x 105 T cells from DO11.10 mice (BALB/c background) were added per well along with a 
fragment of a chicken ovalbumin (cOVA323-339) to 10 μM in 200 μl of medium. DO11.10 mice 
express transgenes in their T cell receptors such that they recognize cOVA323-339. After 48 h of 
culture, supernatants were harvested and assayed for cytokine production by ELISA. Addition of 
CGRP-exposed ECs significantly enhanced IL-6 and IL-17A production compared to wells containing 
non-treated ECs while significantly inhibiting interferon-γ (IFNγ) and IL-4 responses. When T cells 
were harvested from cultures set-up in this manner and analyzed by FACS for intracellular cytokines, 
increased numbers of cells containing IL-17A were seen with a decrease in cells containing IFNγ 
or IL-4. Quantitative RT-PCR was performed on RNA extracted from T cells from these cultures. A 
significant increase in mRNA for RORγT was seen along with decreased levels T-bet and GATA3. 
These data suggest that CGRP biases the outcome of antigen presentation towards a Th17-type 
immune response through actions on ECs. Dermal blood vessels and lymph nodes are innervated 
and nerves reportedly have a role in the expression of human psoriasis. Furthermore, CGRP has been 
suggested to be important in psoriasiform dermatitis in a murine model in which the angiopoietin 
receptor Tie2 is over-expressed in keratinocytes. Thus, this pathway might play a role in psoriasis 
and, perhaps, other inflammatory skin diseases.    
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Norepinephrine (NE) polarizes Langerhans cell (LC) antigen presentation to T cells towards 
a Th17 response via actions on a murine endothelial cell (EC) line
W Ding, LL Stohl, M Manni, JA Wagner and RD Granstein Weill Cornell Medical College, 
New York, NY
NE inhibits the ability of LCs to present antigen to a Th1 clone and intradermal administration of 
NE inhibits the sensitization phase of contact hypersensitivity. We now report that exposure of the 
transformed BALB/c brain-derived EC line bEnd.3 (used as a surrogate for dermal microvascular 
ECs) to NE induces them to bias LC antigen presentation toward differentiation of Th17 helper cells. 
bEnd.3 cells (1 x 104/well) were plated in 96-well round bottom plates in medium containing 10-6 M 
or 10-5 M of NE. After 3 h, plates were washed 4 times and 1 x 104 BALB/c LCs and 2 x 105 CD4+ T 
cells from DO11.10 mice (BALB/c background) were added to each well followed by addition of a 
fragment of chicken ovalbumin (cOVA323-339) to 10 μM in 200 μl of medium. DO11.10 mice express 
transgenes in their T cell receptors such that they recognize cOVA323-339. After 48 h, supernatants 
were assayed for cytokine content by ELISA. Addition of NE-exposed bEnd.3 cells significantly 
enhanced IL-6 and IL-17A production accompanied by inhibition of interferon-γ (IFNγ) and IL-4 
compared to wells containing non-treated bEnd.3 cells or LCs and T cells without bEnd.3 cells. 
When T cells were harvested from these cultures and analyzed by FACS for intracellular cytokines, 
increased numbers of cells containing IL-17A were observed with a decrease in cells containing 
IFNγ or IL-4. RNA was extracted from T cells from these cultures; by quantitative RT-PCR the 
presence of NE-treated bEnd.3 cells led to a significant increase in mRNA for IL-17A and RORγT 
while levels of T-bet and GATA3 mRNA were decreased. Thus, NE can influence the outcome of 
antigen presentation towards a Th17-type immune response through actions on ECs. As dermal 
blood vessels and lymph nodes are associated with sympathetic nerves, we hypothesize that when 
the sympathetic nervous system is activated by stress, NE release from nerves may exacerbate 
psoriasis and, perhaps, other inflammatory skin disorders by biasing antigen presentation towards 
the Th17 pole via actions on ECs.    
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Langerin-CD11b- cells are a murine, classical, Flt3L-dependent dermal DC
SA Mollah,1 JS Dobrin,1 RA Feder,1 S Tse,2 I Matos,1 C Cheong1 and N Anandasabapathy2,3 1 
Cellular Physiology and Immunology, Rockefeller University, New York, NY, 2 Dermatology, 
Brigham and Women’s Hospital, Boston, MA and 3 Harvard Medical School, Boston, MA
Skin derived dendritic cells (DC) are potent antigen presenting cells, playing a critical role in the 
initiation of adaptive immune responses. Murine skin contains several distinct Dendritic Cell (DC) 
subsets in the steady state that continuously migrate to the skin draining lymph node (LN). Lan-
gerin-CD11b- dermal DC are a low-frequency, heterogeneous, uncharacterized skin DC subset, 
comprising less than 20% of all migratory DC in the steady state LN. In prior work, we character-
ized Langerin-CD11b- DC as Fms-like tyrosine kinase 3 ligand (Flt3L) dependent and responsive, 
CX3CR1 (fractaline receptor) low and CD24+, which may relate them to CD11b (low) classical 
DCs such as CD8α DC in LN. Here we demonstrate these cells can be localized to the dermis by 
immunofluorescence as distinct from Langerin CD103+ dermal DC, migrating epidermal LCs and 
Langerin-CD11b+ dermal DC. CD11b- dermal DC present OVA protein with equal efficiency to 
other skin resident DC including Langerhans cells, CD103+ Langerin+ DC, and to CD8α cross-pre-
senting DC of the LN. Langerin-CD11b- DC were found to be Zbtb46 dependent–and like other 
classical DC deplete rapidly in Zbtb46-DTR (diphtheria toxin receptor) mice. We observe these cells 
relate closely to classical DC by transcriptome analysis and express core DC signature genes that are 
different from monocyte derived-DC, LPS-treated CD205+ DC, or macrophages. This work suggests 
the previously overlooked Langerin- CD11b- DC population is likely an important contributor to 
the immune microenvironment.    
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Altered dendritic cell composition during the priming phase of vaccinia immunization
S Tse1,2 and N Anandasabapathy1,2 1 Dermatology, Brigham and Women’s Hospital, Boston, 
MA and 2 Harvard Skin Disease Research Center, Harvard Medical School, Boston, MA
The cutaneous microenvironment is critical to generate protective immunity through the skin, yet the 
cellular requirements underlying productive immunization remain incompletely characterized. We 
have determined the composition and kinetics of migratory and lymph node (LN) resident classical 
dendritic cells (DC) in the skin draining LN during skin scarification with vaccinia virus (VACV), a 
murine model for smallpox immunization. During VACV infection migratory DC numbers peaked 
at 12 hours while a more gradual expansion of classical DC was observed. Analysis of individual 
classical DC subsets revealed expansion of CD11b+CD8α-CD64+ cells above CD8α classical 
DC, whereas expanded numbers of all migratory DC subsets were noted. No change in CD80 and 
CD86 expression was detected across all DC subsets, suggesting DC did not alter their maturation 
status during VACV infection. Using a VACV strain expressing GFP, we detected GFP+ LN DC at or 
prior to 24 hours, but not at 48 or 72 hours. These results suggest that DC licensing occurs acutely 
during infection and perhaps irrespective of maturation status. Future work will clarify the role of 
individual DC subsets in viral presentation and DC licensing during the generation of protective 
immunity with VACV.    
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Role of macrophage migration inhibitory factor (MIF) in pollen-induced allergic conjunctivitis 
and pollen dermatitis in mice
Y Nagata,1 Y Yoshihisa,1 K Matsunaga,1 N Kitaichi2 and T Shimizu1 1 Dermatology, 
University of Toyama, Toyama, Japan and 2 Ophthalmology, Health Sciences University of 
Hokkaido, Sapporo, Japan
Pollen is a clinically important airborne allergen and one of the major causes of allergic conjuncti-
vitis. A subpopulation of patients with atopic dermatitis (AD) are also known to have exacerbated 
skin eruptions on the face, especially around the eyelids, after contact with pollen. This pollen-in-
duced skin reaction is now known as pollen dermatitis. MIF is a pluripotent cytokine that plays an 
essential role in allergic inflammation. Recent findings suggest that MIF is involved in several allergic 
disorders, including AD. In this study, MIF knockout (KO), MIF transgenic (Tg) and WT littermate 
mice were immunized with ragweed (RW) pollen or Japanese cedar (JC) pollen and challenged via 
eye drops. We observed that the numbers of conjunctiva- and eyelid-infiltrating eosinophils were 
significantly increased in RW and JC pollen-sensitized MIF Tg compared with WT mice or MIF 
KO mice. The mRNA expression levels of eotaxin, interleukin (IL)-5 and IL-13 were increased in 
pollen-sensitized eyelid skin sites of MIF Tg mice. An in vitro analysis revealed that high eotaxin 
expression was induced in dermal fibroblasts by MIF combined with stimulation with IL-4 or IL-13. 
This eotaxin expression was inhibited by the treatment with CD74 siRNA in fibroblasts. These find-
ings indicate that MIF can induce eosinophil accumulation in the conjunctiva and eyelid dermis 
exposed to pollen. Therefore, targeted inhibition of MIF might be a promising new therapeutic 
strategy for pollen-induced allergic conjunctivitis and pollen dermatitis.    
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VEGF-A promotes IL-17A-producing γδ T cell accumulation in mouse skin and serves as a 
chemotactic factor for plasmacytoid dendritic cells
T Suzuki,1 S Hirakawa,1 T Shimauchi,1 T Ito,1 J Sakabe,1 M Detmar2 and Y Tokura1 1 
Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan and 2 Institute 
of Pharmaceutical Sciences, Swiss Federal Institute of Technology, Zurich, Switzerland
Th17 cells and their cytokines are deeply involved in psoriasis by stimulating epidermal keratino-
cytes to proliferate and to produce cytokines/chemokines and vascular endothelial growth factor 
(VEGF)-A. Plasmacytoid dendritic cells (pDCs) exacerbate the Th17-mediated pathogenesis. We 
addressed the initiative role of VEGF-A in the development of psoriasis and the pDC accumula-
tion. Skin-infiltrating T cells and pDCs were examined in wild type (WT) mice and K14-VEGF-A 
transgenic (Tg) mice exhibiting spontaneous psoriasis-like lesions. We identified pDCs as 440c+ 
cells by immunohistochemistry and as PDCA-1+B220+ cells by flow cytometry. By using splenic 
pDCs isolated from WT mice, we investigated the VEGF receptor (VEGFR) expression in pDCs by 
flow cytometry and the ability of VEGF-A to chemoattract pDCs by real-time chemotaxis assay. We 
found that the number of dermal IL-17A+ γδ T cells, but not CD4+ T cells, was increased in VEGF-A 
Tg mice, suggesting that the main source of IL-17A was γδ T cells in mice. Skin samples from Tg 
mice showed IL-17A and IL-23p19 expressions by Western blotting. CCL20, a chemokine for γδ T 
cells, was expressed by dermal fibroblasts, and its expression was increased in VEGF-A Tg mice. By 
double-staining, dermal-infiltrating γδ T cells bore CCL20 receptor CCR6. More interestingly, pDCs 
infiltrated at a higher frequency in VEGF-A Tg than WT mice. pDCs, but not γδ T cells, isolated from 
the skin expressed VEGFR1 and VEGFR2. Freshly isolated splenic pDCs expressed both receptors 
after 48-hour cultivation. pDCs did not produce cytokines in response to VEGF-A, however, they had 
a strong velocity of chemotaxis toward VEGF-A at a comparable level to chemerin. These findings 
suggest that VEGF-A functions as not only a downstream enhancer but also an upstream initiator 
by chemoattracting pDCs in psoriatic lesions.    
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Regulatory T cells prevent egress of activated T cells from lymph nodes after application of 
contact sensitizers via degradation of ATP
K Mahnke, RM Koch and AH Enk Dpt. of Dermatology, Ruprecht-Karls-University, 
Heidelberg, Germany
Application of contact sensitizers to the skin can stimulate danger signals such as release of ATP, 
which activate T cells and lead to sensitization of the affected individuals. In a murine model of 
TNCB-induced contact hypersensitivity (CHS) we found that injection of Treg is able to block sensi-
tization against haptens and we also noted increased size and cellularity of the skin draining lymph 
nodes (LN). This led us to hypothesize that Treg may regulate the egress of T cells from LN. When 
analyzing the LN 2-3 h after sensitization, we found that T cells downregulated the major LN homing 
receptor CD62L. In contrast, when Treg were injected before applying the hapten, downregulation 
of CD62L was prevented and increased numbers of T cells in LN could be recorded. Among the 
putative molecules responsible for CD62L downregulation, we found that ATP was produced at 
the site of antigen application and in vitro experiments confirmed shedding of CD62L in T cells by 
ATP. Moreover, when Treg were added to T cell cultures the ATP-induced shedding of CD62L was 
abolished. As underlying mechanism we identified expression of the ectonucleotidase CD39 by 
Treg, which degrades ATP and prevents CD62L shedding. These results were further confirmed by 
investigations using Treg from CD39 deficient mice, because CD39 -/- Treg were not able to block 
CD62L shedding in vitro and in vivo. Moreover, upon injection CD39 -/- Treg failed to abolish the 
sensitization phase of CHS reactions. Thus, this data indicate that Treg are critically involved in 
regulating LN homing of T cells by degrading ATP via CD39.    
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Antigen presentation of dendritic cells via DEC205 is regulated by Casein kinase II
RM Koch, AH Enk and K Mahnke Dept. of Dermatology, Ruprecht-Karls-University, 
Heidelberg, Germany
The dendritic cell (DC) antigen receptor DEC205 takes antigens into MHC-II+ compartments. Its 
intracellular routing is guided by a 31 aminoacid long intracellular domain, containing a putative 
casein kinase II (CKII) phosphorylation site. At first we wanted to localize CKII in DC during anti-
gen uptake and found transient colocalization of DEC205 and CKII approx. 30 min after uptake of 
antigen. Moreover, in vitro phosphorylation assays confirmed that the DEC205 molecule can be a 
target for CKII mediated phoshorylation. To investigate the function of CKII during antigen uptake in 
detail, we generated fusionreceptors containing the HuIgG-binding, extracellular domain of human 
CD16 and the intracellular DEC205 domain (CD16:DECCKII), which harbours a mutated CKII site. 
When analyzing the intracellular distribution of CD16:DECCKII in stably transfected celllines, we 
found a strongly reduced surface expression and no recycling between intracellular compartments 
and the cell surface, as observed for wild type DEC205 (CD16:DECWT). Insteadt, CD16:DECCKII 
accumulated in trans-golgi compartments and targeting to MHC class II+ compartments was omitted. 
In line with this, CD16:DECCKII receptors were impaired to mediate antigen presentation to CD4 and 
CD8 T cells. Thus this data show that phosphorylation of endocytic receptors by CKII is crucial for 
targeting to late endosomal compartments and may have an impact on antigen presentation and 
generation of T cell immunity by DC in vivo.    
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The AhR-agonist 4-n-nonylphenol exerts immunosuppressive features by primarily modu-
lating dendritic cells
A Schwarz,1 A Bruhs,1 J Krutmann2 and T Schwarz1 1 Department of Dermatology, University 
Kiel, Kiel, Germany and 2 Leibniz Research Institute for Environmental Medicine, Düsseldorf, 
Germany
The main function of the arylhydrocarbon receptor (AhR), a widely expressed ligand activated 
transcription factor, is the detoxification of small weight molecular toxins. Ultraviolet radiation 
(UVR) was found to activate the AhR in a ligand-independent fashion. This appears to be involved 
in UVR-induced immunosupppression, since AhR knock-out mice turned out to be resistant to 
UVR-induced immunosuppression. In turn, activation of the AhR by the agonist 4-n-nonylphenol 
(NP) inhibited the induction of contact hypersensitivity (CHS) and induced regulatory T cells (Treg) 
similar to UVR. To identify the target cell in NP-induced immunosuppression, NP-treated and 
TNBS-coupled bone marrow-derived dendritic cells (BMDC) were injected s.c. into naïve mice. 
Recipients turned out to be unresponsive to sensitization against the contact allergen TNCB and 
generated regulatory T cells, as shown by adoptive transfer experiments. This indicated that NP 
exerted immunosuppression by primarily affecting antigen-presenting cells. Since IL-2 is a critical 
cytokine for the homeostasis, function and differentiation of Treg in the periphery, secretion of IL-2 
by BMDC was measured. The analysis of supernatants revealed that upon stimulation with NP 
IL-2 production was significantly upregulated, indicating that NP-stimulated BMDC might induce 
peripheral Treg via enhanced secretion of IL-2. To further elucidate the underlying mechanisms, 
BMDC were cultured for eight days in the presence or absence of NP. A toxic effect of NP was 
excluded by death assays and annexin V/7-AAD staining. FACS analysis of NP-stimulated BMDC 
revealed unchanged expression of major histocompatibility complex class II. However, the negative 
regulatory molecules B7-H3 and 4 were significantly upregulated by NP, whereas the expression of 
B7-H1 was not affected. Together, these data suggest e that NP induces Treg by primarily modulat-
ing antigen-presenting cells and shifting their phenotype from a stimulatory into a regulatory one.   
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Reduction of IL-31 expression during therapy of CTCL correlates with improved pruritus
F Cedeno-Laurent,1 EM Singer,1 BM Benoit,1 M Wysocka,1 G Yosipovitch,2 KJ Ellen1 and 
AH Rook1 1 Dermatology, University of Pennsylvania, Philadelphia, PA and 2 Dermatology, 
Temple University, Philadelphia, PA
Pruritus is one of the most common and debilitating symptoms observed among cutaneous T cell 
lymphoma (CTCL) patients. Pruritus in CTCL is often recalcitrant to conventional treatments with 
anti-histamine and neuroleptic drugs, but seems to subside upon successful treatment with lym-
phoma-targeted therapies. IL-31 is a short-chain 4-helix bundle cytokine thought to be produced 
primarily by skin-homing (CCR4+/CLA+) Th2 cells and by clonal malignant T cells, and which 
recently has been suggested as an important mediator of pruritus in atopic dermatitis and CTCL. 
Notably, higher IL-31 serum levels correlate linearly with the degree of pruritus experienced. We 
hypothesize that treating patients with CTCL may reduce the expression of IL-31 and concomitantly 
help to suppress their pruritus. Here, we first show that in vitro treatment of primary malignant T cells 
with corticosteroids or the histone deacetylase (HDAC) inhibitor vorinostat, significantly reduces 
the level of IL-31 at the mRNA and protein level. Similarly, we compared IL-31 expression from 
malignant and non-malignant T cell populations before and after in vivo treatment with another 
HDAC inhibitor (romidepsin) or the novel humanized anti-CCR4 monoclonal antibody, currently in 
phase III clinical trial. Our data reveal that both treatments effectively mitigate pruritus in patients, 
and that response directly correlates with lower levels of IL-31. These data reveal the relevance 
of blocking the IL-31 pathway for symptomatic relief of patients with intractable pruritus in CTCL 
and potentially other conditions    
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The extracellular matrix controls dendritic cell migration by TLR4 recognition of hyaluronan
J Muto,1,2 AF Carlin,2 M Kim,1,2 A Garcia,3 A Varki2 and RL Gallo1,2 1 Dermatology, 
University of California, San Diego, San Diego, CA, 2 Department of Medicine, University of 
California, San Diego, San Diego, CA and 3 Pathology, University of California, San Diego, 
San Diego, CA
To test if the breakdown of hyaluronan (HA) in the extracellular matrix acts as an endogenous 
signal of injury we generated transgenic mice that conditionally overexpressed Hyaluronidase 1 
(HYAL1). When HYAL1 was constitutively expressed, these mice showed extensive degradation 
of HA yet were morphologically normal. However, the timing of HA breakdown could block or 
accelerate antigen presentation. When mice constitutively overexpressed HYAL1 by K14-Cre (K14/
HYAL1) they had a greatly decreased contact hypersensitivity reaction (CHS) to DNFB (p<0.001). 
Decreased CHS was due to inability to sensitize, as transfer of lymph node (LN) cells from control 
sensitized mice to K14/HYAL1 restored full CHS. The defect in sensitization was explained by 
significant decrease of dendritic cells (DCs) in the epidermis (p<0.001) and the dermis (p<0.05). 
To examine the dynamic nature of DC response, a tamoxifen-inducible K14-dependent Cre system 
(K14CreERT/HYAL1) was used. Inducible expression of HYAL1 by tamoxifen resulted in significant 
loss of epidermal DCs (p<0.001) and increased DC migration to draining LN (p<0.05). Similar to the 
K14-Cre constitutive expression of HYAL1, if tamoxifin was applied 7 days before sensitization then 
CHS was inhibited. In contrast, if K14CreERT/HYAL1 mice were treated with tamoxifen immediately 
before sensitization, the CHS response was accelerated to only 1.5 days after sensitization, a time 
when control mice have not yet developed the capacity to respond to the antigen (p<0.001). CHS 
could also be accelerated by administration of HA tetrasaccharides, and did not occur in any mice 
when bred into Tlr4-/- background, thus showing that TLR4 detection of HA fragments triggered 
the DC migration. Thus, we provide direct evidence that HA breakdown controls the capacity of 
the skin to present antigen. These observations show how HA can be a therapeutic strategy for 
modification of diseases influenced by DCs.    
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IFN-alpha diminishes the suppressive activity of human FOXP3+ regulatory T cells via cAMP 
deprivation
V Raker,1 N Bacher,1 C Hofmann,1 E Graulich,1 M Schwenk,1 R Baumgrass,2 T Bopp,3 
U Zechner,4 L Merten,4 C Becker1 and K Steinbrink1 1 Dermatology, University Medical 
Center, Mainz, Germany, 2 German Rheumatism Research Centre (DRFZ), Berlin, Germany, 
3 Immunology, Johannes Gutenberg-University, Mainz, Germany and 4 Institute of Human 
Genetics, University Medical Center, Johannes Gutenberg-University, Mainz, Germany
The type I interferon IFN-α is a clinically approved therapeutic drug used in a variety of malignant 
disorders, such as malignant melanoma and cutaneous T cell lymphoma. We found that IFN-α 
reduces the suppressive capacity of human Treg in vitro and in a xenogenic GvHD mouse model 
in vivo. Further evaluation of IFN-α-mediated Treg inactivation revealed that IFN-α diminishes the 
high intracellular concentrations of cyclic adenosine monophosphate (cAMP) that are essential for 
Treg-mediated suppression. IFN-α-induced cAMP repression was blocked with the non-selective 
phosphodiesterase inhibitor IBMX as well as with the PDE4 (highly expressed in T Cells) specific 
inhibitor rolipram. Pretreatment with an ERK-specific inhibitor prohibited the IFN-α induced cAMP 
degradation in Treg, disclosing MAP kinases-dependent regulation of PDE4 activity. However, 
IFN-α-mediated Treg inactivation neither affected Foxp3 TSDR (Treg specific demethylated region) 
methylation state which is shown to be required for the stability of FOXP3 expression and function 
nor the anergic state of Treg excluding an impact on the Treg differentiation program. In conclusion, 
IFN-α acts as a potent regulator of human Treg activity downregulating their suppressive function 
without affecting lineage stability.    
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Keratinocyte death in severe cutaneous adverse drug reactions is mediated by necroptosis 
pathway of annexin A1/ FPR1 interaction
N Saito, T Yanagi, S Shinkuma, A Suto, Y Fujita, S Suzuki, T Nomura, H Nakamura, 
H Shimizu and R Abe Hokkaido University Graduate School of Medicine, Sapporo, Japan
Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) are life-threatening adverse drug 
reactions characterized by blister formation and widespread skin detachment involving keratinocyte 
death. The mechanism of keratinocyte death in SJS/TEN remains unclear. Recently, an alternative 
mechanism of cell death has been discovered: necroptosis, which is programmed necrosis mediated 
by receptor-interacting proteins (RIPs). Necroptosis-mediated disease had been unknown until 
now. Here we show that SJS/TEN are necroptosis -mediated diseases induced by the pathway of 
annexin A1 and formyl peptide receptor1 (FPR1) interaction. We found that the dead keratinocytes 
in SJS/TEN lesions showed morphological necrosis. The supernatant from the causative-drug-stim-
ulated peripheral blood mononuclear cells of patients with SJS/TEN induced the death of SJS/TEN 
keratinocytes. The keratinocytes from healthy controls were unaffected by SJS/TEN supernatant. 
These cytotoxicities were blocked by RIP1 inhibitor or knockdown of RIP3 with siRNA but not 
by pan-caspase inhibitor. Mass spectrograph analysis identified annexin A1 as a key mediator of 
keratinocyte death from the fact that depletion of annexin A1 prevented such death. With SJS/TEN 
supernatant, SJS/TEN keratinocytes expressed abundant FRP1, a receptor of annexin A1, whereas 
control keratinocytes did not. In addition, FRP1 expressions were detected in the skin lesions of 
SJS/TEN patients. Finally we developed an SJS/TEN therapy that targets necroptosis using a blocker 
(necrosulfonamide: NSA) in SJS/TEN model mice. Whereas the vehicle-treated model mice showed 
marked conjunctival congestion, NSA-administered mice showed no such manifestations. These 
data clearly indicate that necroptosis is a promising target for SJS/TEN treatment and that NSA is 
a therapeutic candidate.    
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Very early tumor-infiltrating dendritic cell change their characteristics from immunoinhibi-
tory to immunostimulatory in association with tumor progression
T Nakahara,1,2 J Oba2 and M Furue1,2 1 Division of Skin Surface Sensing, Dermatology, 
Kyushu University, Fukuoka, Japan and 2 Dermatology, Kyushu University, Fukuoka, Japan
Dendritic cells (DC) have a critical effect on the outcome of adaptive immune responses against 
growing tumors. Whereas it is generally assumed that the presence of phenotypically mature DCs 
in tumor should promote protective antitumor immunity, evidence to the contrary does exist. 
Tumor-infiltrating dendritic cells (TIDC) have an ambivalent role in regulation of tumor regression 
or growth, but the characteristics that distinguish these effects are obscure. In this study, we inves-
tigated the frequency, phenotype and function of TIDC over time from very early stages in murine 
melanoma inoculation model. Flow cytometric analysis of infiltrating cells isolated from melanoma 
inoculation site revealed that the tumors are infiltrated by a significant population of CD11c+MHCII+ 
DC especially at very early stage of tumor growth. TIDC infiltration constituted about 40% of total 
infiltrating cells harvested from the tumor site at day2. The proportion of TIDC increased until day 4 
and then gradually decreased by day 14. TIDC were phenotypically more mature than resident DC 
in draining lymph nodes, as demonstrated by their higher expression of CD86. Allogenic stimulatory 
capacity of TIDC increased with tumor growth while the capacity of DC in LNs decreased. When 
TIDC were co-injected with melanoma, TIDC harvested at early stages of the tumor (early TIDC) 
accelerated tumor growth, but TIDC harvested at advanced stages (late TIDC) delayed the tumor 
progression in vivo. Furthermore, co-injection of early TIDC induced much less IFN-g than late 
TIDC within tumor microenvironment. These results indicated that TIDC changed their characteristic 
from immunoinhibitory to immunostimulatory over time in association with tumor progression.   
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Psoriasiform phenotype in K5.Stat3C transgenic mice depends on the IL-23/Th17 axis through 
interleukin 36 receptor-mediated TLR signaling
K Ohko, K Nakajima and S Sano Dermatology, Kochi University, Nankoku, Kochi, Japan
Psoriasis is a chronic inflammatory skin disease due to crosstalk between immune cells and kerati-
nocytes. We have demonstrated that K5.Stat3C transgenic mice develop psoriasis-like skin lesions, 
which resemble human psoriasis in symptom, histopathology, and immunological pathomechanism 
such as involvement of the IL-23/Th17 axis. It was suggested that IL-36, a member of the IL-1 family 
of cytokines, plays a role in development of psoriasis, since IL-36 cytokines are overexpressed 
in psoriatic lesional skin. More recently, missense mutations in the IL-36RN gene were found in 
patients with generalized pustular psoriasis. Furthermore, mouse experiments using several trans-
genics and knockouts revealed the importance of the IL-36 receptor (R) signal in the development 
of psoriasisform skin lesions. However, the detail relationship between IL-36 signals and the IL-23/
Th17 axis in psoriasis lesion still remains unclear. Real-time RT-PCR demonstrated that TPA-induced 
psoriasis-like lesions in K5.Stat3C mice showed up-regulation of IL-36 genes. To investigate whether 
IL-36R signal were required for generation of the lesions, we crossed IL-36R knockout with K5.Stat3C 
transgenic mice. Ear swelling was greatly attenuated in TPA-induced early response and so was 
psoriasis-like epidermal hyperplasia in IL-36R-/-:K5.Stat3C mice compared with control K5.Stat3C 
mice. Gene expression of psoriasis-related molecules including the IL-23/Th17 axis and S100As 
was down-regulated in IL-36R-/-:K5.Stat3C mice. To examine whether TLR sinals are required for 
IL-36R in immune cells, we cultured spleen cells in vitro with a TLR7 agonist imiquimod (IMQ). 
ELISA using culture supernatants revealed that spleen cells from control mice produced elevated 
levels of TNF and IL-12/23p40 by IMQ stimulation; however, their production was completely 
abolished in spleen cells from IL-36R-/- mice. Therefore, these results strongly suggested that IL-36R 
signaling was required for innate immunity leading to upregulation of the IL-23/Th17 axis and 
resulting psoriasiform phenotype in K5.Stat3C mice.    
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High expression of TSLP receptors in circulating CD4+ T cells in atopic dermatitis
K Tatsuno, T Fujiyama, H Yamaguchi and Y Tokura Dermatology, Hamamatsu University 
School of Medicine, Hamamatsu, Japan
Recent studies have suggested that thymic stromal lymphopoietin (TSLP) activates Langerhans cells 
to induce the differentiation of naïve T cells into Th2 cells. TSLP is overtly expressed on skin lesions 
of atopic dermatitis (AD), and previous documentations underscore the contributory role of TSLP 
in the pathogenesis of AD via this type of dendritic cells (DCs). Meanwhile, TSLP receptor (TSLPR) 
is expressed on various immunocompetent cells, including mast cells, basophils, eosinophils, 
monocytes, and T cells, indicating the possibility of direct TSLP interaction with these cells. We 
therefore investigated the expression of TSLPR, focusing on T cells. In freshly isolated peripheral 
blood mononuclear cells (PBMCs), TSLPR expression was minimal (0.045% of PBMCs). However, 
upon stimulation with PMA and Ca ionophore, the expression of TSLPR was strongly upregulated 
on CD14+ monocytes and CD11c+ myeloid DCs (0.224%). This stimulation, however, did not 
enhance the expression of TSLPR on T cells. Interestingly, freshly isolated PBMCs from AD patients 
demonstrated increased frequencies of TSLPR+CD4+ T cells (average, 0.40% of PBMCs), while 
other cell types, including CD14+ monocytes and CD11c+ mDCs, exhibited virtually no TSLPR 
expression. Circulating TSLPR+CD4+ T cells were observed at higher frequencies in 30 AD patients 
than in healthy controls (p<0.05). TSLPR+ T cells were CCR4+, CXCR3-, CLA+, CCR7-, CCR10+, and 
CD45RO+, indicative of skin-homing effector CD4+ T cells. Furthermore, ~25% of TSLPR+CD4+ T 
cells had a CD25+Foxp3+ phenotype. Thus, circulating TSLPR+CD4+ cells in AD patients seemed 
to consist of largely 3/4 of Th2 and 1/4 of Treg cells. Finally, CD4+ T cells isolated from PBMCs 
of AD were cultured with anti-CD3/CD28 Abs with or without rhTSLP. The supernatants showed 
modulated production of IL-2, IL-4, IL-10, TNF-a, IFN-g, and IL-17A. These observations newly 
suggest that CD4+ T cells of AD patients possess strong potential to directly interact with TSLP to 
modulate the inflammatory process via the highly expressed TSLPR.    
017
Two distinct subsets of skin-infiltrating memory T cells, TRM and TEM, define cutaneous immune 
responses against systemically-administered soluble antigens
G Egawa, Y Miyachi and K Kabashima Department of Dermatology, Kyoto University, Kyoto, 
Japan
Cutaneous immune reactions to soluble antigens, such as drugs, are common, but their precise 
pathomechanism remains unclarified. To this end, we newly developed a murine model for skin 
eruptions against soluble antigens using ovalbumin (OVA)-specific TCR transgenic line, OT1. OT1 T 
cells were adoptively transferred to naïve mice and were immunized with OVA/CFA. Five days later, 
antigen non-specific skin inflammation was induced to the right ear with topical phorbol myristate 
acetate (PMA) treatment, which induced skin-resident memory T cells (TRM), a recently-identified 
subset of memory T cells. Two weeks after PMA-painting, a large number of CD103+CD69+ OT1-
TRM were found in the epidermis of PMA-painted site, whereas only a marginal number of OT1 T 
cells were detected in the untreated left ear. Then, OVA peptide (257-264) was injected intrave-
nously, which exhibited immediate ear swelling response with elevated IFN-γ production only in 
the right ear where OT1-TRM exist in the epidermis. Five days after the systemic administration of 
OVA peptide, CD44+CD62L- effector memory OT1 T cells (TEM) were significantly increased in the 
blood and, intriguingly, were detected in the dermis of the untreated left ear. In addition, a repeated 
intravenous administration of OVA peptide developed chronic necrotic skin lesion even without 
extrinsic stimuli. These observations implicate respective roles of TRM and TEM in cutaneous immune 
responses. Antigen-specific TRM in the epidermis cause immediate and localized skin eruptions that 
resemble to fixed drug eruption, whereas expansion of drug-sensitive TEM in the blood that infiltrate 
into dermis induce delayed-type chronic skin inflammation, e.g., disseminated drug eruptions.   
018
Programmed cell death1 (PD-1) regulates the effector function of autoimmune CD8 T cells 
via the ligands expressed on target epidermal cells
N Okiyama and SI Katz Dermatology Branch, NCI, Bethesda, MD
PD-1 is an inhibitory molecule expressed by activated T cells. Its ligands (PD-L1 and -L2) are 
expressed by a variety of leukocytes and stromal cells. Blocking this receptor/ligand pair has been 
shown, in humans, to enhance immune responses. To assess the role of PD-1 in CD8 T cell-me-
diated diseases, we used PD-1 knockout (KO)-OVA-specific T cell-receptor transgenic (Tg) CD8 T 
cells (OT-I cells) in a murine model of cutaneous graft-versus-host disease (GVHD). We found that 
mice expressing OVA on squamous epithelial cells (mOVA mice), after transfer of as few as 5 × 104 
PD-1-KO OT-I cells, developed significant GVHD-like skin and mucosal lesions with significant 
weight loss, while those after transfer of 5 × 104 wild-type or Fas-KO OT-I cells did not. As well, 
mOVA×OT-I double Tg (DTg) mice that do not develop GVHD after adoptive transfer of 1 × 106 
OT-I cells, develop GVHD-like disease in a Fas/Fas-L independent manner when 1 × 106 PD-1-KO 
OT-I cells are transferred. These results suggest that PD-1/PD-L1/2 pairing has stronger inhibitory 
effects on effector CD8 T cells than does the Fas/Fas-L-pairing. FACS analysis demonstrated that 
keratinocytes from mOVA mice 10 days after transfer of 1 × 106 OT-I cells overexpressed PD-L1 
(mean fluorescence intensity, MFI: 20.5 ± 1.1) compared to keratinocytes from B6 mice (MFI: 3.7 ± 
0.2, p<0.01; t-test). Primary mOVA keratinocytes expressed PD-L1 when stimulated by interferon-γ 
in vitro. When co-cultured with mOVA keratinocytes for 2 days, PD-1-KO OT-I cells exhibited 
enhanced (4 ×) proliferation compared to wild-type OT-I cells. The PD-1-KO OT-I cells also overex-
pressed activation markers, CD44 and CD25, compared to wild-type OT-I cells. In addition, knock-
down of 50% PD-L1 expression on the keratinocytes with transfection of PD-L1-siRNA enhanced 
OT-I cell proliferation. In aggregate, our data strongly suggest that PD-L1, expressed on activated 
target keratinocytes presenting autoantigens, regulates autoaggressive CD8 T cells, and inhibits the 
development of mucocutaneous autoimmune diseases.    
ABSTRACTS | Adaptive Immunity 
S4   Journal of Investigative Dermatology (2014), Volume 134
019
New insights into epidermal and dermal compartments of lesional and non-lesional atopic 
dermatitis skin using laser capture micro-dissection
H Esaki,1,2 DA Ewald,1,3 M Suarez-Farinas,1 H Mitsui,1 J Krueger1 and E Guttman1,2 1 
Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, 2 
Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY and 3 
Molecular Biomedicine, LEO Pharma, Ballerup, Denmark
Atopic dermatitis (AD) is the most common, chronic skin disease, and is associated with intractable 
pruritus. Identification of pathogenic molecules that initiate and/or maintain inflammatory circuits 
in AD skin plays a critical role in developing new therapeutic approaches. Laser capture micro-dis-
section (LCM) is a useful method to separate various skin layers. In this study, we used LCM to 
separate epidermis and dermis and performed gene-arrays and RT-PCR to investigate the genomic 
profiling of the epidermis and dermis compartments of lesional and non-lesional skin of severe AD 
patients. Using this technique and criteria of > 2 FCH, p< 0.05, we identified a larger number of 
genes (780 up-regulated and 422 down-regulated genes in the epidermis; 452 up-regulated and 
368 down-regulated in the dermis), in comparison to the established AD transcriptome (defined as 
differentially expressed genes between lesional and non-lesional AD skin). These results substan-
tially enlarged the AD transcriptome and categorized genes as primarily epidermal or dermal. We 
also detected low abundance genes, such as IL-22 and TSLP, that are below detection levels with 
conventional gene-array methods using bulk skin biopsies. Using this novel approach we detected 
for the first time in a human skin disease, a novel epidermal cytokine, IL-34, recently reported in 
mice to control Langerhans cell differentiation and proliferation during the maintenance phase. IL-34 
showed lower mRNA expression in lesional compared with non-lesional epidermis. LCM provides 
a useful method to increase detection of low abundance genes in AD and enables tissue-specific 
information, leading to increased understanding of the inflammatory pathways involved in the 
epidermal and dermal compartments of lesional and non-lesional skin.    
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Epigenetic modulation via histone deacetylase (HDAC) 6 inhibition impairs CD8 T cell func-
tions during skin inflammation
G Tsuji, N Okiyama, V Villarroel and SI Katz Derm Branch, CCR, NCI, NIH, Bethesda, MD
HDAC6 is a unique enzyme that regulates cell functions via epigenetic modification of non-histone 
proteins such as heatshock protein 90 (HSP90). Since we found that HDAC6 expression on CD8 
T cells was 3.22-fold increased compared with that on CD4 T cells in anti-CD3/CD28 antibody 
(Ab)-stimulated murine splenocytes (p<0.05, t-test), we examined whether HDAC6 inhibition mod-
ified CD8 T cell functions in vivo using ACY-1215 (ACY), an HDAC6-specific inhibitor, currently 
being evaluated clinically. ACY (75 mg/kg twice daily by gavage) was given to mice in a CD8 T cell 
dependent and CD4 T cell, including Treg, independent murine model of graft-versus-host disease 
(GVHD), using transgenic mice expressing ovalbumin (OVA) in skin with adoptive transfer of OT-I 
cells. Clinical and histological examination showed that ACY attenuated skin inflammation 11 days 
after OT-I transfer and reduced the development of weight-related GVHD [weight loss: -23.2% 
(vehicle) and -11.2% (ACY) 5 days post OT-I cell transfer (p<0.05)]. ACY administration increased 
acetylation of HSP90 in skin draining lymph node T cells. FACS analysis showed modulated expres-
sion of OT-I cell activation markers (CD25, CD44 were reduced and CD62L was enhanced) by 
ACY (p<0.05). qRT-PCR analysis showed that, compared to control, ACY (in vitro-1 μM) suppressed 
IL-2 and IFN-γ upregulation induced by OVA peptide by 76.1% (p<0.05) and by 63.0% (p<0.05), 
respectively. To clarify the molecular basis of these changes, we analyzed anti-CD3 Ab-stimulated 
Jurkat cells incubated with ACY (1 μM). Western blots showed that ACY 1) enhanced expression of 
acetylated-HSP90 binding to Lck; 2) inhibited phosphorylation of Lck, ZAP-70 and LAT, but not Fyn; 
and 3) inhibited phosphorylation of JNK1/2 and p38, but not ERK1/2. Considering that acetylation 
of HSP90 mediates its cochaperone functions, the data indicate that epigenetic modification of 
the HSP90-Lck complex via HDAC6 inhibition impairs T cell signaling. Thus, HDAC6 may be a 
novel target for treatment of CD8 T cell-mediated inflammatory skin disorders, including GVHD.   
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EpCAM expressed by epidermal Langerhans cells modulates topical immunization to proteins
T Ouchi and MC Udey Dermatology Branch, CCR, NCI, NIH, Bethesda, MD
Langerhans cells (LC) are required for efficient formation of Type 2 (IgG1 and IgE) Ab in response to 
foreign proteins that are applied to intact, lightly tape-stripped skin without adjuvant. Immunization 
is mediated via LC that extend dendrites through tight junctions (TJ) to acquire topically applied 
Ag and subsequently migrate to regional lymph nodes (LN) where they prime naïve lymphocytes. 
EpCAM (CD326) is expressed at high levels by LC. We have previously reported that EpCAM pro-
motes LC dendrite mobility, as well as LC migration within epidermis and from epidermis to regional 
LN in response to contact sensitizers. We have also demonstrated that, in epithelial cells, EpCAM 
regulates the levels of expression and distribution of selected claudins (TJ-associated proteins). We 
hypothesized that in the absence of EpCAM, acquisition of Ag by LC might be impaired and topical 
immunization to proteins might be attenuated. To test this, we studied conditional KO mice with 
EpCAM-deficient LC (cKO mice). Surprisingly, cKO and control (WT) LC dendrites docked with and 
penetrated the epidermal TJ after light tape stripping with equal efficiencies. LC from both strains 
internalized surface biotinylated self-proteins to similar extents. Surprisingly, topical immunization 
of cKO mice with ovalbumin (Ova) led to the accumulation of increased (rather than decreased) 
numbers of LC in regional LN. This was accompanied by enhanced proliferation of adoptively 
transferred Ova-reactive OT-II transgenic T cells and enhanced formation of Ova-specific Ab in cKO 
mice. These results indicate that EpCAM regulates topical immunization to proteins acting via LC, 
but immunization is potentiated by EpCAM deficiency instead of inhibited as predicted. We propose 
that EpCAM-dependent mechanisms that regulate LC migration may differ in important ways in the 
setting of limited inflammation associated with topical immunization with proteins as compared 
with the intense inflammation triggered by application of strong contact sensitizers. Unraveling 
EpCAM’s precise role in these situations will require additional experimentation.    
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Early defect in cutaneous immune responses to varicella zoster virus challenge in old 
individuals
M Vukmanovic-Stejic,1 J Fuentes-Duculan,3 D Sandhu,2,1 T Sobande,1 M Suarez-Farinas,3 
E Agius,1,2 J Krueger,3 M Rustin2,1 and A Akbar1 1 Infection and Immunity, University College 
London, London, United Kingdom, 2 Dermatology, Royal Free Hospital, London, United 
Kingdom and 3 Investigative Dermatology, Rockefeller University, New York, NY
A marked increase in the susceptibility to skin infections and malignancies has been observed in 
older humans indicating that cutaneous immunity becomes defective with age. As Varicella Zoster 
Virus (VZV) often reactivates in old individuals, resulting in shingles, we studied the kinetics of the 
cutaneous response to VZV skin test antigens in young and old subjects (<40 years old and >65 
years respectively). We found that the old subjects have reduced clinical responses to intradermal 
challenge VZV despite showing equivalent PBMC proliferative responses to VZV antigens in vitro. 
In young individuals both CD4+ and CD8+ T cells accumulated at the site of VZV injection, 
peaking at day 7, whereas T cell accumulation was significantly reduced in the old group which 
correlates with the reduced clinical score. The expression of E-selectin, VCAM and ICAM-1 was 
also significantly reduced on endothelial cells in the skin of old individuals after VZV challenge. To 
understand the mechanism responsible for lack of responsiveness in the old skin we examined the 
transcriptional profile of gene expression of young and old skin after VZV challenge and found a 
reduced inflammatory signature in the old subjects. Collectively this suggests a decreased ability to 
condition the skin for leucocyte infiltration in response to VZV challenge in old individuals. There 
were no differences in the numbers of resident T cells, DCs and macrophages in control or VZV 
challenged skin after 6 hours between young and old individuals. There was however an increase 
in proportion of Foxp3+CD4+ cells in the skin of old individuals before any antigenic challenge 
and this inversely correlated with the magnitude of the clinical response. One possibility therefore 
is that in old subjects, these cells may inhibit the normal cascade of events that are required to 
induce the immune response in the skin after VZV challenge.    
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Platelet-activating Factor-receptor agonists generated by chemotherapy thwart host anti-tu-
mor immunity
R Sahu, JA Ocana, M Ferracini, RL Konger and JB Travers Indiana University, Indianapolis, IN
Previous studies have established that pro-oxidative stressors suppress host immunity due to their 
ability to generate oxidized glycerophosphocholine (Ox-GPC) lipids with Platelet-activating Fac-
tor-receptor (PAF-R) agonist activity. Because many chemotherapeutic agents also induce reactive 
oxygen species, the present studies were designed to define if chemotherapeutic agents could 
thwart host anti-tumor immunity against melanoma via PAF-R activation. We demonstrate that 
treatment of melanoma cell lines in vitro and tumors in vivo with chemotherapeutic agents generates 
PAF-R-agonists in a process blocked by antioxidants, indicating the involvement of non-enzymatic 
PAF-R-agonists. Mass spectrometry studies revealed that chemotherapeutic agent treatment of 
B16F10 melanoma cells generated novel Ox-GPCs. In a model system consisting of implantation 
of two tumors, we show that intratumoral chemotherapy with melphalan or etoposide of one tumor 
significantly augments the growth of the other (untreated) tumor in wild-type but not PAF-R-deficient 
hosts. Chemotherapeutic agent-mediated PAF-R-dependent increased tumor growth is blocked 
by systemic administration of antioxidants and cyclooxygenase-2 (COX-2) inhibitors. In addition, 
depleting antibodies against regulatory T cells (Tregs) significantly attenuated chemotherapy-me-
diated growth of untreated tumors, suggesting the role of Tregs in this process. Moreover, we show 
that COX-2 inhibitors blocked PAF-R-mediated increase in intratumoral Tregs. Finally, use of mass 
spectrometry revealed high levels of PAF-R agonists in perfusates of patients with melanoma under-
going isolated limb chemoperfusion with melphalan. These findings provide evidence for a novel 
and previously unappreciated pathway by which Ox-GPC PAF-R agonists produced as a by-product 
of chemotherapy modulate tumor growth via the inhibition of anti-tumor immunity. These studies 
might explain some instances of chemotherapy treatment failure and offer insights into potential 
therapeutic strategies that could enhance the overall anti-tumor effectiveness of chemotherapy.   
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The extracellular ATP/ATPase axis is critical for skin-resident T cell immunity in UV-induced 
skin cancer
AS MacLeod,1 D Zelac,2 R Rudolph3 and WL Havran1 1 Department of Immunology 
and Microbial Science, The Scripps Research Institute, La Jolla, CA, 2 Department of 
Dermatology, Scripps Clinic, La Jolla, CA and 3 Department of Plastic Surgery, Scripps 
Clinic, La Jolla, CA
Skin-resident T cells are critical for controlling squamous cell carcinomas (SCC), which are often 
associated with chronic UV radiation (UV). However, regulation of human skin-resident T cell 
and murine dendritic epidermal γδ T cell (DETC) function by UV is not known. Here, we find 
that skin-resident T cells become activated by UV-induced extracellular ATP (eATP), shown by 
increased proliferation, CD69 levels, and changes in DETC morphology; and contribute to the 
keratinocyte DNA repair response. A role of skin-resident T cells in DNA repair was supported by 
findings that i) γH2AX, a marker for DNA double strand breaks, was substantially reduced in WT 
compared to Tcrδ-/- mouse skin following UV, and ii) treatment of human keratinocyte cultures 
with supernatants from activated human skin-resident T cells reduced the frequency of γH2AX+ 
cells following UV, suggesting increased keratinocyte DNA repair in the presence of skin-resident 
T cells. Mechanistically, UV-induced eATP served as a potent danger signal to induce or enhance 
skin-resident T cell and DETC IL-17 secretion, which was in part mediated through P2X7 recep-
tor and caspase-1-dependent IL-1 secretion from keratinocytes. IL-17, in turn, induced epidermal 
GADD45 and TWEAK, two molecules linked to DNA repair. These findings demonstrate a novel 
role for skin-resident T cells in the UV response and the importance of eATP signaling to skin 
immunity. However, ecto-ATPases, such as ENTPD1, control eATP levels and are often associated 
with immunosuppression. SCC, in contrast to normal human skin, showed strong accumulation 
of stromal ENTPD1+CD14+ cells, suggesting that ATPases may contribute a microenvironment 
conducive to UV-induced skin cancer. Further characterization of the role of eATP and ATPases in 
skin-resident T cell function may identify new therapeutic targets for skin cancer.    
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Gene profiling of epidermal Langerhans stimulated with TSLP
S Miyamoto, M Shibata and J Hosoi Shiseido Research Center, Yokohama, Japan
Langerhans cells (LCs) have long been considered to be the major sensitizing cells in the skin by 
initiating immunity in naive resting T cells. But it is not clear how langerhans cells change their 
characteristics in a state of activation, such as atopic dermatitis. We examined the expression of 
genes in potently activated CD34-positive progenitor-derived dendritic cells from cord blood as an 
in vitro alternative for langerhans cells. The cells were exposed to human thymic stromal lymph-
opoietin (TSLP) for 6 and 16h. Using microarray analyses we revealed a set of 497 genes with an 
altered gene expression pattern after exposure to TSLP. Upregulated genes were mainly categorized 
into 5 groups: chemokines, cytokines, transcription-associated factors, apoptosis, neural-associated 
factors. The expression of CXCL10 (Homo sapiens chemokine (C-X-C motif) ligand 10 ) and OX40 
ligand related to atopic dermatitis are significantly increased. These results suggest the possibility 
that these phenotypic changes of langerhans cells affect immune reaction    
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Langerhans cells are extinguisher of over reaction to environmental stress
J Hosoi, S Miyamoto, K Inoue and H Aoki Shiseido Research Center, Yokohama, Japan
The purpose of this study is to demonstrate that epidermal Langerhans cells extinguish the ignition of 
over reaction to environmental stimuli to the skin. Langerhans cell-like cells (LCLC) were prepared 
from cord-blood-derived CD34-positive cells. LCLC or THP-1, human monocyte leukemia cells, 
were added to the culture of normal human epidermal keratinocytes followed by stimulation with 
ATP. The amount of ATP in the culture medium was measured by commercially available luciferase 
assay kit. Cytokine and chemokine expression was determined by ELISA or quantitative RT-PCR. 
For alfaMSH measurement keratinocytes were cultured as multi-layer form on the culture insert and 
airexposed. ATP is reportedly released from keratinocytes by various situmulation. CD39 molecule 
was expressed on LCLC and THP-1 cells. Interestingly cord blood-derived CD34-positive cells did 
not express CD39 before differentiation culture. The stimulation of ATP release by UV from kerati-
nocytes was reduced by addition of LCLC. IL-6, IL-8, CXCL-1, CXCL-2, and CXCL-3 were increased 
by addition of ATP and the induction was suppressed in the presence of LCLC but not of LCLC 
treated with siRNA for CD39. Secretion of alfaMSH from air-exposed multilayered keratinocytes 
was increase by ATP and the stimulation was suppressed in the presence of LCLC, suggesting the 
relation to melanogenesis in epidermis. These results demonstrate that Langerhans cells maintain the 
skin homeostasis by quenching extracellular ATP with CD39 on their surface. Epidermal Langerhans 
cells are, therefore, surveyor of various stimuli as well as pathogens.    
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Propionibacterium acnes promotes Th17 and Th17/Th1 responses in acne patients
M Kistowska,1 B Meier,1 T Proust,1 L Feldmeyer,2 A Cozzio,1 T Kuendig,1 E Contassot1 and 
LE French1 1 Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland 
and 2 Department of Dermatology and Venereology, Centre Hospitalier Universitaire 
Vaudois, Lausanne, Switzerland
Propionibacterium acnes is a gram positive commensal bacterium thought to be involved in the 
pathogenesis of acne vulgaris. While the ability of P. acnes in the initiation of pro-inflammatory 
responses is well documented, little is known about adaptive immune responses to this bacterium. 
The observation that infiltrating immune cells consist mainly of CD4+ T cells in the perifollicular 
space of early acne lesions suggests that helper T cells may be involved in immune responses 
caused by the intra-follicular colonization of P. acnes. In this work, we show that both Th1 and 
Th17 effector cytokines, transcription factors and chemokine receptors are strongly upregulated in 
acne lesions. We also found that P. acnes-exposed peripheral blood mononuclear cells or CD4+ T 
cells secrete IL-17A (Th17 phenotype) or concomitantly IL-17A and IFNγ (mixed Th17/Th1 pheno-
type). P. acnes-specific Th17 and Th17/Th1 cells were found to be present in the peripheral blood 
of healthy individuals and, at higher frequencies in patients suffering from acne. Our data suggest 
that the modulation of Th17- and Th17/Th1-mediated immune responses may consist in a novel 
therapeutic option for acne.    
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IL-37 induces tolerogenic dendritic cells and suppresses skin contact hypersensitivity
Y Luo,1 X Cai,1 S Liu,1 S Wang,1 S Li,2 CA Nold-Petry,3 MF Nold,3 P Bufler,4 DA Norris,1 
CA Dinarello2 and M Fujita1 1 Dermatology, University of Colorado Denver, Aurora, CO, 
2 Medicine, University of Colorado Denver, Aurora, CO, 3 The Ritchie Centre, Monash 
University, Melbourne, VIC, Australia and 4 Children’s Hospital, Ludwig-Maximilians 
University, Munich, Germany
IL-1 family member IL-37 inhibits innate immunity. Although IL-37 is expressed in human blood 
monocytes and dendritic cells (DCs), the role of IL-37 in adaptive immunity has remained elusive. 
Here we utilize a strain of transgenic mice expressing human IL-37 (IL-37tg) to investigate the role 
of IL-37 in DCs and the development of skin contact hypersensitivity (CHS) to specific antigen. 
CHS to hapten challenge was markedly decreased in IL-37tg mice compared to wild-type (WT) 
mice. The distribution, phagocytotic activity and migration of skin DCs to regional lymph nodes 
in IL-37tg mice were comparable to those from WT mice. However, adoptive transfer of sensitized 
DCs from IL-37tg mice (IL-37-DCs) to WT mice impaired CHS responses to hapten challenge com-
pared to mice receiving DCs from WT mice (WT-DCs). The expression of IL-37 in DCs attenuated 
LPS-induced upregulation of costimulatory molecules CD40 and MHC II and secretion of IL-1β, 
IL-6 and IL-12 whereas it enhanced IL-10 secretion. Consistent with these data, IL-37-DCs exhibited 
decreased stimulation of naïve T cells from syngeneic and allogeneic mice, reduced activation of 
antigen-specific T cells to DNBS and enhanced T regulatory cell induction. Similar to IL-1α and 
IL-33, IL-37 functions intracellularly and extracellularly by translocating to the nucleus to affect 
transcription. Whereas recombinant IL-37 inhibited LPS-induced IL-1α production, it did not affect 
DC function, indicating that IL-37-induced DC suppression is mediated intracellularly. Microarray 
analysis revealed a series of immune genes and pathways differentially expressed between WT-DCs 
and IL-37-DC. In conclusion, IL-37 expression in DCs induces tolerogenic DCs, leading to the 
inhibition of adaptive immunity.    
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A cutaneous CD30+ T-cell lymphoma spontaneously resolving and recurring on the same 
skin sites
C Haddadeen,1 C Lai,1 S Cho,1 A Fityan,1 A Bates,2 J Theaker3 and E Healy1 1 Dermatology, 
University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, 2 
Oncology, University Hospital Southampton NHS Foundation Trust, Southampton, United 
Kingdom and 3 Histopathology, University Hospital Southampton NHS Foundation Trust, 
Southampton, United Kingdom
We present a novel case of a spontaneously resolving cutaneous CD30+ T-cell lymphoma which 
subsequently recurs at the same skin sites. A 78-year-old Caucasian male presented with a 47 year 
history of a relapsing and remitting, scaly, red rash which reappeared at the same skin sites on 
the trunk and limbs several times a year, with each bout persisting up to two weeks. The eruption 
consisted of patches and plaques and would spontaneously resolve without ulceration or scarring. 
A skin biopsy revealed an infiltrate of small CD3+ lymphocytes with numerous large pleomorphic 
lymphoid blast cells which extended into the epidermis and were positive for CD30, negative 
for CD4 and CD8, with no obvious evidence of malignant transformation. T-cell receptor gene 
polymerase chain reaction studies demonstrated a clonal T cell population. These findings were 
suggestive of a cutaneous CD30+ T-cell lymphoma. During remission of the rash, a skin biopsy 
demonstrated a focus of perivascular lymphocytic infiltrate in the upper dermis but failed to reveal 
the presence of cells expressing CD30. The WHO-EORTC classification system of cutaneous lym-
phoma includes primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis 
as a subgroup of primary cutaneous CD30+ lymphoproliferative disorders. While the histological 
features of this case are comparable to those of lymphomatoid papulosis, the clinical features of 
non-scarring patches and plaques instead of papulo-nodules suggests that this variant of cutaneous 
CD30+ T cell lymphoma has not been classified to date and hence we suggest this patient’s rash 
represents a novel disease which we have termed ‘lymphomatoid plaquosis’.    
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 IL-17 regulates Th17-mediated inflammatory and antimicrobial defense responses induced 
by Propionibacterium acnes
GW Agak,1 Y Yu,1 M Qin,1 AJ Park,1 J Okhovat,1 W Zhu,1 S Krutzik,1 HJ Garban1 and J Kim1,2 
1 Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA and 2 Dermatology, 
Greater Los Angeles Healthcare System Veterans Affairs, Los Angeles, CA
We have recently demonstrated that IL-17-expressing cells are present in skin biopsies from acne 
patients, and that Propionibacterium acnes is a potent inducer of Th17-related effectors molecules, 
including IL-17 and IL-22. The purpose of this study was to investigate whether silencing of IL-17 
and IL-22 using small interference RNA (siRNA) modulates Th17-related inflammatory, chemotactic 
activity and antimicrobial responses induced by P. acnes. P. acnes stimulated PBMCs demonstrated 
elevated expression of antimicrobial peptides (AMPs); psoriasin (S100A7), defensins (DEFB4), cathe-
licidins (LL-37) and antimicrobial chemokines; CXCL-1/-9/-10/-11 and CCL15. siRNA-mediated 
knockdown of IL-17 not only led to the loss of capacity to express S100A7, DEFB4 and LL-37 upon 
P. acnes stimulation, but also suppressed the secretion and expression of Th17-related functional 
molecules, including CCL20, IL-17, IL-21, and IL-22. However, knocking-down IL-22 alone, sup-
pressed AMP expression, but had no effect on the expression of key genes known to directly signal 
Th17 responses including IL-17, RORα and RORc. Additionally, we observed that, both IL-17 and 
IL-22 genes are required for antimicrobial chemokines CXCL1 and CXCL10 expression, but not 
CXCL9, CXCL11 and CCL15. Overall, silencing IL-17 by RNA interference modulates P. acnes 
-induced Th17-mediated inflammatory response and chemotactic activity, which may be critical 
for directing the immune response to sites of infection and injury and, the cytokine IL-22 may 
play a role in ameliorating the IL-17-driven chronic inflammatory responses initiated by P. acnes.   
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Proteomic analysis of CRH-treated regulatory T cells in atopic dermatitis
S Jin,1,2 J Noh,1 J Kim,3 J Shin,1 C Park,1 N Lee1 and K Lee1,2 1 Department of Dermatology 
& Cutaneous Biology Research Institute, Seoul, Republic of Korea, 2 Brain Korea 21 PLUS 
Project for Medical Science, Yonsei University College of Medicine, Seoul, Republic of Korea 
and 3 Korea Basic Science Institute, Daejeon, Republic of Korea
Regulatory T (Treg) cells are a subset of T cells with strong immunosuppressive activity. However, 
increased number and percentage of Treg cells in patients of atopic dermatitis (AD) may suggest 
abnormal function of Treg cells with decreased or absent immunosuppressive activity. Therefore, 
the aim of this study was to discover disease specific proteins in corticotropin-releasing hormone 
(CRH)-treated Treg cells. Female NC/Nga mice were applied with Biostir-AD for six weeks. Spleno-
cytes from AD mice were treated with 10 nM CRH for 24 and 48 hours, and Treg cells were sorted. 
Differential protein expression between CRH-treated group and non-treated group was compared 
by Tandem Mass Tag labeling method. After sensitizing NC/Nga mice for six weeks, we observed 
AD-like skin lesions and elevated serum IgE levels in mice. The percentage of CD4+ IL-4+ TH2 cells 
was also increased in the spleen of these mice. The purity of MACS sorted Treg cells was approxi-
mately 80%, and these Treg cells expressed both of the CRHR1 and CRHR2. Initially, we identified 
about 1300 proteins in CRH-treated and non-treated Treg cells. Afterwards, we attempted to identify 
proteins that either increased or decreased depending on time after stimulation with CRH before 
identifying final 28 proteins as candidates for further investigation. We found 6 up-regulated proteins 
including chromobox protein homolog 1 and 22 down-regulated proteins including dedicator of 
cytokinesis (DOCK) family protein. Among these down-regulated proteins, we paid special attention 
to DOCK family protein because of its role in various immune diseases, and through Western blot, 
we confirmed decrease of DOCK protein in a time dependent manner in CRH-treated Treg cells. 
In conclusion, decrease of DOCK family protein in CRH treated Treg cells may be associated with 
abnormal immunosuppressive activity of Treg in AD.    
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Maintenance of cutaneous immune reactions by regulatory T cells in a newly developed 
murine model of graft-versus-host like skin disease
S Nakajima,1 G Egawa,1 W Amano,1 J Sakabe,2 Y Tokura,2 Y Miyachi1 and K Kabashima1 
1 Dermatology, Kyoto University Graduate School of Medicine, Kyoto, Japan and 2 
Dermatology, Hamamatsu University Graduate School of Medicine, Hamamatsu, Japan
Regulatory T cells (Tregs) control autoimmunity to maintain immune homeostasis via suppressing 
self-reactive T cells. However, underlying mechanisms how they maintain immune reactions in 
the skin remain unclear due to the lack of good animal models. To this end, we newly generated 
transgenic mice that express a membrane-bound form of ovalbumin (OVA) under the control of 
the involucrin promoter (ivl-mOVA). By transferring naive OVA-specific CD8+ T cells of the OT-I 
transgenic mice, ivl-mOVA mice spontaneously developed graft-versus-host disease (GVHD)-like 
dermatitis seven days after the transfer. Apoptotic keratinocytes in the epidermis and sub-epidermal 
blisters were observed by hematoxylin and eosin staining. Intriguingly, GVHD-like dermatitis was 
resolved spontaneously in one month when we found that CD4+ Foxp3+ Tregs infiltrated into the 
skin and skin draining LNs prominently. The ratio of CD4+ Foxp3+ cells to CD4+ Foxp3- cells in the 
draining LNs was markedly increased in the resolution phase, which suggests that Treg terminated 
GVHD-like skin lesions. To assess the in vivo function of Tregs, we crossed ivl-mOVA mice with 
human CD2-CD52 knock-in reporter mice, such that all Foxp3-expressing cells co-express the fusion 
protein on their cell surface. We therefore generated ivl-mOVA mice which can be depleted Foxp3 
positive cells by administrating anti-human CD2 antibody. We found that systemic Treg depletion 
of ivl-mOVA mice led to exacerbation of the GVHD-like dermatitis compared to Treg non-depleted 
mice. Immunohistochemical analysis revealed that Tregs co-localized with CD11c+ dendritic cells 
(DCs), suggesting that Tregs might maintain immune reactions via affecting DCs in the skin. Taken 
together, Tregs accumulate into the skin after the development of skin inflammation in order to 
resolute immune reactions to skin-associated antigen.    
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Interferon-γ-induced signaling pathways in cancer cell growth arrest
T Wieder, E Brenner, K Braungart, M Hahn, S Assmann, S Weidemann, H Braumüller and 
M Röcken Dermatology, University Medical Center, Tübingen, Germany
p16Ink4a/retinoblastoma protein (Rb)-dependent cell cycle regulation is impaired in various tumors, 
including HPV-positive epithelial cancers or merkel cell carcinoma. A well-established model for 
these cancers is a RIP-Tag2 mouse expressing the T antigen (Tag) under control of the rat insulin 
promoter (RIP). Similar to the human situation, Tag-induced inactivation of p53 and partial inhibition 
of the p16Ink4a/Rb pathway lead to uncontrolled proliferation of the β-cells, and finally to β-cell 
cancer. We previously showed that Tag-specific, interferon-γ (IFN-γ)- and tumor necrosis factor 
(TNF)-producing T helper 1 (Th1) cells strongly reduce β-cell tumor mass thereby doubling the 
survival of the mice. This Th1 cell-based antitumor effect is mediated by IFN-γ- and TNF-induced 
permanent cancer cell growth arrest (senescence) in the absence of cancer cell killing. Here, we 
analyzed the IFN-γ-dependent signaling pathways leading to cellular senescence in vitro. Using 
PCR array analysis, we repeatedly found up regulation of TNF mRNA after IFN-γ stimulation of the 
β-cancer cells. These results were confirmed by quantitative rtPCR, and TNF mRNA was already up 
regulated after 4 h of incubation. Immune-fluorescence double staining for TNF and insulin further 
demonstrated IFN-γ-induced TNF in isolated β-cancer cells. In accordance with a functional role 
of TNF for IFN-γ-induced senescence, RIP-Tag2xTNFR1-deficient cells were less sensitive towards 
growth inhibition and did not show any signs of senescence, i.e. senescence-associated β-galac-
tosidase activity or nuclear recruitment of pHP1γ, after IFN-γ treatment. Taken together, our data 
demonstrate that IFN-γ induces TNF in a functional autocrine loop, and the two cytokines then 
arrest β-cancer cell proliferation by restoring cell cycle control. This nontoxic mechanism of cancer 
control leads to cancer cell senescence and may thus in part explain the protection that interferons 
provide to patients at increased risk of developing melanoma metastases.    
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Periostin contributes to a Th2-dominant environment of cutaneous T-cell lymphoma via 
thymic stromal lymphopoietin expression
N Takahashi, M Sugaya, H Suga, T Miyagaki, H Ohmatsu, M Kawaguchi, H Fujita, Y Asano, 
Y Tada, T Kadono and S Sato Department of Dermatology, Faculty of Medicine, University 
of Tokyo, Tokyo, Japan
Periostin, an extracellular matrix protein, acts as a critical mediator for amplification and chronicity 
of allergic skin inflammation through production of thymic stromal lymphopoietin (TSLP), which 
activates dendritic cells to induce Th2 response. It has been recently reported that periostin is 
highly expressed in skin tissues of atopic dermatitis (AD) patients and that serum periostin levels 
correlated with disease severity. In this study, we aimed to investigate the role of periostin and 
TSLP in cutaneous T-cell lymphoma (CTCL). We first examined messenger RNA (mRNA) levels of 
periostin, TSLP, and other disease severity markers in skin samples of CTCL (n = 23) and in control 
normal skin (n = 5). Although periostin mRNA levels in CTCL lesional skin were not elevated, they 
significantly correlated with levels of TSLP (r = 0.70, P < 0.01), CCL17 (r = 0.48, P < 0.05), IL-4 (r = 
0.44, P < 0.05), and IL-22 (r = 0.37, P < 0.05). TSLP mRNA expression levels also correlated with 
IL-22 mRNA levels (r = 0.37, P < 0.05). When fibroblasts from CTCL skin (n = 6) were stimulated 
with IL-4 (10 ng/ml), they expressed higher mRNA levels of periostin compared to those from 
normal skin (n = 5; P < 0.01). Immunohistochemistry revealed enhanced periostin expression in 
the upper dermis and increased TSLP expression in the epidermis of CTCL lesional skin, similar to 
what is seen with AD skin. Furthermore, serum periostin levels in patients with CTCL (n = 46) were 
significantly higher than in control samples (n = 16; P < 0.05). Serum periostin levels significantly 
correlated with levels of LDH (r = 0.28, P < 0.05) and CCL17 (r = 0.39, P < 0.05). Interestingly, 
SeAx, a CTCL cell line, expressed TSLP receptor and stimulation of SeAx with TSLP increased IL-4 
mRNA expression (P < 0.05). These results suggest that periostin contributes to a Th2-dominant 
environment of CTCL via TSLP expression.    
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Naive T cells give rise equally to TCR-identical TRM and TCM after skin antigen exposure
O Gaide,1 RO Emerson,3 X Jiang,1 S Nizza,1 C Desmarais,2 H Robins,2,3 R Clark1 and 
TS Kupper1 1 Dermatology, Brigham and Women’s Hospital, Boston, MA, 2 Adaptive 
Biotech, Seattle, WA and 3 Fred Hutchinson Cancer Research Center, Seattle, WA
T cell immune memory resides in different anatomic compartments such as lymph nodes (LN), in 
the form of central memory T cells (TCM), and peripheral tissues, as resident memory T cells (TRM). 
We studied the relationship between these two subsets of memory T cells generated after antigen 
encounter in a model barrier tissue: skin. Instead of employing transgenic mice whose T cells have 
only a single αβ T cell receptor (TCR), we used a powerful new tool —high-throughput sequencing of 
TCR’s— to track many thousands of T cells between tissue samples. We tested three diverse antigenic 
challenges broadly relevant to human disease—a chemical hapten, a protein, and a virus—and used 
wild-type mice to observe in vivo immune responses. Here we show that during the memory phase 
of the immune response (>35d), for every expanded skin TRM clone, there exists a TCM clone in LN 
with an identical TCR, and that these TCR-identical clones are present in similar numbers. This 
indicates common origin from a single naive T cell, but these sequencing data further suggest that 
the TCR repertoire of TRM in tissue—and thus their antigen specificity— is mirrored by TCM in LN. 
Though after a simple immunization, these skin TRM and corresponding LN TCM clones are present 
in similar numbers, repetitive antigen exposure to skin expanded skin TRM clones preferentially over 
their TCR-identical TCM counterparts. Our results show that murine contact hypersensitivity (CHS), 
the counterpart of human allergic contact dermatitis, is a TRM-mediated disease and does not require 
circulating T cells. However, TCM can give rise to skin TRM after hapten re-exposure. We speculate 
that TRM are designed evolutionarily to allow for rapid local responses to pathogens, but that their 
activities are subverted in several chronic human diseases affecting barrier tissues.    
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Characterization of cutaneous Th17 CD4+ TRM with heterogeneous migratory properties 
after candida infection of skin
X Fu,1 C Park,1 X Jiang,1 R Watanabe,1 R Clark,1 RC Fuhlbrigge,1 C Lin2 and TS Kupper1 1 
Dermatology, Brigham and Women, Boston, MA and 2 Wellman Laboratories, Boston, MA
Most TRM studies in murine skin have studied the now well characterized CD8+ TRM after viral 
infection. In contrast, there is a striking lack of information regarding skin CD4+ TRM in murine 
models, even though most human skin TRM are CD4
+. In this study, we used a cutaneous C. albicans 
(SC5314) infection of dorsal skin, known to produce a predominantly Th17 mediated response in 
lymph nodes. TRM have never been studied in these mice. We were able to demonstrate readily 
that CD4+ T cells existed predominantly in the infected skin during both the effector and memory 
(TRM) phase. We studied skin CD4
+ TRM cells using two photon intravital microscopy. We adop-
tively transferred naïve EGFP+ CD4+ and/or DsRed+ (or EGFP+) CD8+ T cells into RAG1-/- mice 24 
hours prior to cutaneous Candida infection. We found that the majority of infiltrating T cells were 
CD4+ and resided in the dermis, while a minor CD8+ T cell population entered the epidermis. We 
studied the dermal CD4 population at 10(Teff), 30(TRM), and 75 (stable TRM) days after infection. 
Day 10 CD4+ Teff cells had rapid migratory behavior in dermis (mean velocity, 7.07 μm/min; Arrest 
Coefficient (AC) < 25). While most day 30 CD4 TRM had slower migratory properties (2.21 μm/
min; AC > 25) and resided in papillary dermis, a minority of fast-moving T cell persisted in deeper 
dermis (7.13 μm/min; AC < 25). By day 75, 80% of CD4+ TRM were nearly sedentary in the papil-
lary dermis (1.69 μm/min; AC > 50). The remaining 20% of memory CD4+ TRM cells displayed an 
intermediate migratory phenotype (3.44 μm/min; AC < 50); these cells were primarily in the deeper 
dermis. Sedentary CD4+ TRM cells were also observed in uninfected skin (1.65 μm/min; AC > 50). 
As expected, skin CD4+ Teff produced robust IL-17A 10 days after infection. CD4 TRM from both 
infected and uninfected skin also produced abundant IL-17A. These results indicate that Candida 
infection generates dermal Th17 TRM with heterogeneous migratory behavior.    
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 Diverse T cell patterns characterize the different forms of cutaneous graft-versus-host disease 
M Brüggen,1 I Klein,1 H Greinix,2 W Bauer,1 Z Kuzmina,2 W Rabitsch,2 P Kalhs,2 R Knobler,1 
G Stingl1 and G Stary1 1 Dermatology, DIAID, Medical University of Vienna, Vienna, Austria 
and 2 Internal Medicine I, BMT Unit, Medical University of Vienna, Vienna, Austria
Graft-versus-host disease (GVHD) is the major complication of allogeneic hematopoietic stem cell 
transplantation (HCT) and can occur in an acute (aGVHD), and a chronic form (lichenoid (clGVHD) 
or sclerotic (csGVHD)). The mechanisms involved in the initiation and propagation of these diverse 
manifestations remain to be elucidated. To address this issue, we collected lesional skin biopsies 
from patients with aGVHD (n=25), clGVHD (n=17) or csGVHD (n=7), as well as serial skin biop-
sies from HCT recipients at different time points prior/after HCT (n=14). The cellular infiltrate was 
assessed by IF stainings, cytokine/chemokine mRNA by real-time RT-PCR. Cytokine profiles of 
stimulated T cells from lesional skin biopsies and peripheral blood were analyzed by intracellular 
FACS stainings. CD4+ and CD8+ T cells dominated the inflammatory infiltrate in all types of 
GVHD. However, acute cutaneous GVHD was characterized by a Th2 signature, i.e. an increase 
of Th2 cytokines (IL-4, IL-5, IL-13) and chemokines (CCL17, CCL22). Importantly, we also found 
a strong up-regulation of IL-22 and a concurrent increase of cutaneous but not circulating IL-22 
single-producing CD4+ T cells. The expression of TSLP, a keratinocyte-derived cytokine skewing 
the immune response towards a Th2 direction, was increased in the epidermis of patients before 
they developed aGVHD. In contrast to aGVHD, we found a mixed Th1/Th17 pattern in clGVHD, 
as evidenced by the overexpression of Th1/Th17 cytokines/chemokines (IFN-γ, IL-12/IL-23p40 and 
IL-23p19; CCL5, CXCL9, CXCL10) and elevated numbers of skin-localized IFN-γ- and IL-17-pro-
ducing CD8+ T cells. Th1 signals predominated in csGVHD. Our findings provide new insights into 
the T cell-mediated mechanisms operative in the acute and chronic form of cutaneous GVHD and 
allow to more accurately distinguishing them based on different cellular and molecular patterns.   
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Fine tuning of T cell trafficking by skin resident commensals
CO Park,1 V Yeliseyev,2 X Jiang,1 S Nizza,1 T Tian,1 L Bry,2 RC Fuhlbrigge1 and TS Kupper1 
1 Dermatology, Brigham and Women’s Hospital, Boston, MA and 2 Pathology, Brigham and 
Women’s Hospital, Boston, MA
Recent studies have shown that germ free (GF) mice have depressed cutaneous immune responses, 
which can be partially restored by adding back components of the skin microbiome. However, T cell 
trafficking to skin has not been studied. To address this question, we used ovalbumin (OVA)-spe-
cific, TCR-transgenic, murine CD8+ (OT-I) and CD4+ (OT-II) T cells, adoptively transferred into 
GF and specific pathogen-free (SPF) mice. The adoptively transferred naïve OT-I and OT-II cells 
were CFSE-labeled and exclusively naive (CD44-, E-lig-, α4β7-, CD62L+) by FACS. After 24 hours, 
OVA plus adjuvant was applied, and T cell homing markers (E-lig, α4β7, CD62L) were evaluated 
in draining lymph node at days 1, 3, 5, and 7. We observed very rapid proliferation of OT-I and 
OT-II cells in draining LN of both GF and SPF mice at day 3 (OT-I, > 10 cell divisions; OT-II, 8 cell 
divisions). After 5 cell divisions, both OT-1 and OT-II cells began to express E-lig and downregulate 
CD62L but remained negative for α4β7. Both OT-I and OT-II cells had fully proliferated by day 5 
(> 10 cell divisions). There was no difference in kinetics or degree of expression of E-lig or CD62L 
between GF and SPF mice. Significant numbers of OT-I (> 70% of total CD8+ T cells) and OT-II 
cells (~30% of total CD4+ T cells) recruited into the immunized skin in both GF and SPF mice at 
day 5. This decreased to a level of ~30% of total CD8+ T cells and ~10% of total CD4+ T cells, 
respectively, at day 7 in both mice. There was a trend towards a more rapid decrease of tissue 
resident CD8 T cells in germ free skin, but longer time courses (i.e., > 6 months) are required to 
confirm this observation. Taken together, these results imply that while the skin microbiome may 
influence T cell residence in skin, it does not affect either the induction of skin homing molecules 
or the acute inflammatory process.    
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Gaining insight in the pathogenesis of alopecia areata through next generation T cell receptor 
sequencing
JT O’Malley,1 A de Jong,1 A Jabbari,1 Z Dai,1 M Kurban,1 A Christiano1 and R Clynes2 
1 Dermatology, Columbia University Medical Center, New York, NY and 2 Pathology, 
Columbia University Medical Center, New York, NY
Alopecia Areata (AA) is one of the most common autoimmune diseases, characterized by non-scar-
ring hair loss. T-cells play a central role in disease pathogenesis as they abundantly infiltrate the 
hair follicles in AA, and are both necessary and sufficient to transfer disease in the C3H/HeJ mouse 
model of AA. However, the exact antigen or antigens these pathogenic T-cells are targeting remain 
unknown. In an attempt to elucidate the TCR clonality in AA, we have used Next Generation T cell 
receptor (TCR) β-chain sequencing in the C3H-HeJ mouse model to follow the T-cells that appear 
in the skin of these mice over time. This model utilizes a skin graft from a donor mouse with spon-
taneous alopecia to a recipient mouse that subsequently develops alopecia within approximately 
6 weeks. By sequencing the TCR β-chains in recipient skin at 0, 3 and 6 weeks after grafting, we 
determined that the appearance of alopecia coincides with an increase in clonal T cell expan-
sions, suggesting that hair loss is driven by an oligoclonal population of TCRs. Furthermore, we 
have determined that the clonally expanded T-cells are CD8+CD44highCXCR3+CD103+NKG2D+ 
(“NK-type CD8 cells”), which have been previously determined to be the effector T-cells driving 
disease pathogenesis. Interestingly, when characterizing the TCR repertoire of the affected skin in 
both donor and recipient mice, the majority of expanded T-cell clones in the recipient mice differ 
from those of the donor, suggesting that the disease is not simply transferred by transfer of pathogenic 
clones, but rather through an indirect process that results in the activation of new effector CD8+ T 
cells. While many of the TCRs of the donor and recipient mice may differ, we do also detect several 
identical or highly similar CDR3 sequences in the affected skin of different animals, suggesting that 
these pathogenic T-cells do likely recognize shared epitopes.    
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Kinetics of extracorporeal photopheresis induced global monocyte activation
A Mittal, K Liu, J Lewis, D Khalil, H Feng, E Robinson, R Filler, R Tigelaar, R Edelson and 
M Girardi Dermatology, Yale School of Medicine, New Haven, CT
Extracorporeal photopheresis (ECP) in the treatment of CTCL, GVHD and allograft rejection con-
tinues to provoke the question of how ECP induces immunostimulation versus tolerance. It was 
previously demonstrated that ECP leads to stimulation of peripheral blood monocyte-to-dendritic 
cell (DC) differentiation due to repeated contact with plate-adherent activated platelets and serum 
proteins. However, the kinetics of global monocyte activation after ECP had not been well char-
acterized. Using a laboratory model of ECP, we monitored by flow cytometry CD11c+ monocytes 
for co-expression of markers of monocyte activation, HLA-DR and ICAM-1, as well as co-expres-
sion of PLAUR (CD87) that we had shown was increased by mRNA expression in ECP-activated 
monocytes. ECP-passaged CD11c+ monocytes (13 donors, 19 runs) showed a mean 4.5x increase 
in surface HLA-DR (ΔMFI, P<.0001) with a mean 24.7% increase attributable specifically to plate 
contact (P=.001); a mean 15.4x increase in surface ICAM-1 (ΔMFI, P<.0001) with a mean 34.4% 
increase attributable specifically to plate contact (P=.0016); and a mean 4.3x increase in surface 
PLAUR (ΔMFI, P<.0001) with a mean 70.7% increase attributable specifically to plate contact 
(P=.0004). While ICAM-1 and PLAUR expression peaked at 24 hours, HLA-DR expression peaked at 
4 hours. To assess for morphologic complexity associated with monocyte activation, we analyzed the 
ECP-passaged CD11c+ monocytes for changes in forward scatter (FSC; increase in size) and/or side 
scatter (SSC; increase in granularity). ECP-passaged CD11c+ monocytes (6 donors, 6 runs) showed 
a mean 2.75x increase in morphologic complexity (P<.001). Furthermore, when these phenotypic 
and morphologic changes indicative of monocyte activation were compared to cytokine (GM-CSF/
IL-4)-stimulated monocytes, ECP-activated monocytes showed significantly higher levels of ICAM-1 
and PLAUR expression. An understanding of the mechanisms by which ECP globally activates 
CD11c+ monocytes may facilitate optimization and broader application of this immunotherapy   
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A novel population of TRM with potent effector functions and a high proliferative capacity 
exists in human peripheral tissues
R Watanabe, A Gehad, C Yang, J Teague, TS Kupper and R Clark Department of Dermatology, 
Brigham and Women’s Hospital, Boston, MA
Non-recirculating resident memory T cells (TRM) generated as a result of antigenic exposures remain 
long-term in tissues and protect against known pathogens in both mice and humans. In mice, only 
CD103+ intraepithelial γδ and αβ CD8+ TRM have been described. We studied human TRM using 
humanized mice and CTCL patients before and after treatment with alemtuzumab (αCD52), a 
medication that kills recirculating T cells but spares TRM. NSG mice grafted with human foreskin 
were infused with allogeneic human T cells, inducing a GvHD-like dermatitis. Mice were treated 
with αCD52 to deplete recirculating human T cells from skin and TRM were analyzed. Two distinct 
populations of TRM were observed: CD103
+ T cells and CD69+CD103- T cells. Studies of human 
CTCL patients after treatment with αCD52 produced identical results. Two populations of TRM 
existed, both subsets contained more CD4 than CD8 T cells, all were αβ T cells and TRM were present 
in both the dermis and the epidermis. We isolated these distinct populations of TRM from healthy 
human skin. Both populations had robust effector functions (IL-17, IL-22, IFNγ & TNFα production) 
but CD103+ TRM had a low proliferative potential, lost function and underwent apoptosis when 
removed from skin. In contrast, CD69+CD103- TRM were 2-3 fold more numerous, were enriched 
in dermis and proliferated robustly. TCR sequencing revealed both epidermal and dermal TRM had 
a diversity comparable to that of circulating T cells. Both subsets responded to C. alibcans and 
S. aureus, with effector functions predominating in CD103+ and combined cytokine production/
proliferation in CD69+CD103- TRM. Both populations of TRM were also found in human lung and gut. 
The most frequent TRM clones from skin, gut and lung were non-overlapping, suggesting distinct T 
cell pools exist in each tissue. In summary, human peripheral tissues contain a novel population of 
TRM not previously observed in mouse or humans that have marked effector functions and a high 
proliferative capacity.    
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Human tissue tropic TCM: Recirculating tissue tropic T cells with impressive effector functions
A Gehad, J Teague, R Watanabe, V Huang, TS Kupper and R Clark Dermatology, Brigham & 
Women’s Hospital, Boston, MA
Central memory T cells (TCM) express L selectin/CCR7 and are thought to recirculate between blood 
and lymph nodes. TCM can give rise to tissue tropic effector memory cells (TEM) after antigen encoun-
ter in lymph nodes but TCM are not thought to enter peripheral tissues. We found that the majority 
of TCM also expressed skin (CLA) or gut homing (α4β7) receptors, suggesting they are capable of 
entering peripheral tissues. A mean 39% of circulating TCM in blood expressed the skin addressin 
CLA and 21% expressed the gut homing receptor α4β7 integrin. 10-30% of T cells isolated from 
human skin co-expressed skin tropic (CLA/CCR4) and TCM markers. Sézary syndrome is a cancer 
arising from these skin tropic CLA+ TCM, and the accumulation of malignant cells in skin, blood 
and lymph nodes is consistent with the combined lymph node and tissue tropism of these cells. 
In Sézary patients treated with alemtuzumab, a medication that depletes circulating T cells and 
purges the skin over time of recirculating T cells, CLA+ TCM were depleted from skin, confirming 
these cells do recirculate through skin. We studied the functional characteristics of skin and gut 
homing TCM using CyTOF mass spectrometry. Tissue tropic TCM produced similar cytokines as TEM 
tropic for the same tissue, albeit at lower levels. IL-22 and IL-13 were produced at higher levels by 
skin tropic TCM and TEM and IFNγ was produced at high levels by both gut tropic TCM and TEM. All 
subsets produced high levels of TNFα and IL-2. TCM, regardless of tissue tropism, expressed more 
IL-4 than tissue tropic TEM. The one notable exception was production of IL-17A. IL-17A was pro-
duced at high levels by skin tropic TEM but was not produced by any TCM subset. In summary, the 
paradigm that central memory T cells primarily recirculate between blood and lymph nodes needs 
to be updated to reflect the fact that the majority of TCM also have tissue homing capacity. These 
cells likely play significant roles in pathogen responses and in the inappropriate inflammation that 
characterizes inflammatory skin disease.    
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The role of IRF4 in Th2 polarisation in the skin
ME Polak,1 CY Ung,1 J Masapust,1 TC Freeman,2 MR Ardern-Jones1 and E Healy1 1 
Dermatopharmacology, University of Southampton, Southampton, United Kingdom and 2 
Systems Immunology Group, University of Edinburgh, Edinburgh, United Kingdom
The aberrant Th2 immune responses in atopic dermatitis (AD) are coordinated by cutaneous den-
dritic cells (DCs), activated by thymic stromal lymphopoietin (TSLP), highly expressed in lesional 
AD. We sought to elucidate the molecular pathways involved in Th2 priming capacity of human 
skin DC subsets, including Langerhans cells (LCs) and dermal DC (DDCs). Migratory LCs and DDCs 
were matured with TNFa (a Th1/Th17 polarising cytokine) or TSLP either during or post-migration 
(n=3). Both cytokines induced DC migration from biopsies and mature phenotype (expression of 
CD40, CD70, CD80 and CD86). LCs were superior inducers of Th2 priming (n=6, p=0.013), and 
this ability was further enhanced by TSLP (n=3, p=0.01). Whole transcriptome data were obtained 
with Affymetrix HGU219 microarrays from human skin DCs at 0,2,8 and 24h of stimulation with 
either TNFa or TSLP (n=3). Applying MaSigPro algorithm, p<0.05, we have identified 527 genes 
differentially regulated by the two cytokines. The differences in TNFa and TSLP-induced gene 
expression progressed with time (90 genes with signal difference >1.25 at 2h vs 351 genes at 24h). 
Delineation of molecular networks involved in TNFa and TSLP signalling with BioLayout Express3D 
(MCL=1.7, r=0.85) revealed striking differences in regulation of genes involved in antigen capture, 
intracellular trafficking and formation of immunoproteasome, previously determined by us as “LCs 
molecular signature”. Th2 polarising ability of human DCs correlated with early expression of 
interferon regulatory factor 4 (IRF4). While unstimulated migratory LCs expressed significantly higher 
levels of IRF4 than DDCs (n=3, paired t-test: p<0.005), IRF4 expression was further up-regulated 
two-fold in LCs matured with TSLP. Our analysis points to the role of IRF4 as a key transcriptional 
control element of Th2 polarisation in human skin LCs.    
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Identification of skin resident memory CD4+ T cells (TRM) producing IL-17A after cutaneous 
candida infection
CO Park,1 X Fu,2 X Jiang,1 R Watanabe,1 R Clark,1 RC Fuhlbrigge,1 C Lin2 and TS Kupper1 
1 Dermatology, Brigham and Women’s Hospital, Boston, MA and 2 Wellman Center for 
Photomedicine, Massachusetts General Hospital, Boston, MA
While skin CD8+ TRM cells after infection with intracellular viral pathogens have been extensively 
studied, there is still a lack of information on skin CD4+ TRM cells— more specifically on extracel-
lular pathogens including Candida albicans. In this study, we used a cutaneous candidiasis murine 
model infected with C. albicans (SC5314) showing that CD4+ T cells existed predominantly in the 
skin at effector and memory phase. To explore skin CD4+ TRM cells using an intravital microscopy, 
we adoptively transferred naïve EGFP+ CD4+ and/or DsRed+(or EGFP+) CD8+ T cells into RAG1-/- 
mice 24 hours prior to cutaneous candida infection. We first found that predominant CD4+ T cells 
were mainly located in the dermis compared with minor CD8+ T cell population in the epidermis 
and dermis 10 days, 30 days, and 75 days after candida infection. Skin effector CD4+ T cells at day 
10 had high migratory property(mean velocity, 7.07 μm/min; Arrest Coefficient(AC) < 25), while 
most of skin memory T cells at day 30 had slow migratory potential(2.21 μm/min; AC > 25) but still 
fast-moving memory T cells(7.13 μm/min; AC < 25) were observed. Approximately 80% of skin 
memory CD4+ T cells at day 75 were CD4+ TRM cells(1.69 μm/min; AC > 50) compatible with those 
in FTY720-treated mice(1.62 μm/min; AC > 50) and the remaining 20% of memory CD4+ T cells 
had intermediate migratory property(3.44 μm/min; AC < 50) suggesting a presence of recirculating 
memory CD4+ T cells. CD4+ TRM cells were also observed in the uninfected distal skin(1.65 μm/
min; AC > 50). Skin memory CD4+ T cells produced IL-17A in both infected and uninfected distal 
skin, while skin effector CD4+ T cells produced robust IL-17A after candida infection. We also 
found that skin CD4+ TRM cells in FTY720-treated mice produced IL-17A. Collectively, these results 
indicate that widely-generated skin CD4+ TRM cells after cutaneous candida infection have potential 
protective function against C. albicans by producing IL-17A.    
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CD1a autoreactive T cells recognize natural skin lipids
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Human epidermal Langerhans cells express high levels of CD1a, an antigen presenting molecule that 
presents lipid antigens to T cells. Previously, we have shown that human blood and skin contain a 
subset of T cells that is reactive to CD1a, and the presence of this T cell subset under non-inflam-
matory conditions suggests a normal physiological role for these cells in the skin. Autoreactivity is 
a key feature of CD1-restricted T cells and is exemplified by their ability to recognize endogenous 
lipid antigens. The specific natural “self” lipid antigens presented by CD1a molecules have remained 
an open question in the field. Here, we analyzed the ligands present in cell-derived CD1a using 
lipidomics. Further, we used unliganded CD1a to test the antigenicity of lipids from various tissues. 
CD1a released hundreds of ligands of two types: Inhibitory ligands, which were ubiquitous mem-
brane lipids with polar headgroups; and several stimulatory ligands that were identified as highly 
apolar oils lacking such headgroups. We identified triglycerides, fatty acids, wax esters and squalene 
as CD1a autoantigens that naturally accumulate in the stratum corneum and sebum. Since these 
antigens lack polar headgroups groups to interact with T cell receptors, we propose that they activate 
T cells through nesting within the CD1a groove and displacing non-antigenic resident lipids with 
large head groups. The identification of hydrophobic skin lipids as antigens for CD1a-restricted T 
cells points to a novel mechanism of barrier immunity.    
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The fine tuning of T cell trafficking by skin resident commensals
CO Park,1 V Yeliseyev,2 X Jiang,1 S Nizza,1 T Tian,1 L Bry,2 RC Fuhlbrigge1 and TS Kupper1 
1 Dermatology, Brigham and Women’s Hospital, Boston, MA and 2 Pathology, Brigham and 
Women’s Hospital, Boston, MA
Recent studies have shown that skin microbiota regulate resident T cell function in cutaneous 
inflammation using germ-free(GF) mice. However, how normal skin commensals affect T cells 
homing to inflamed skin is yet unknown. To test this possibility, we used an ovalbumin(OVA)-spe-
cific, TCR-transgenic, murine CD8+(OT-I) and CD4+(OT-II) T cell adoptive transfer model with 
GF and specific pathogen-free(SPF) mice. We adoptively transferred CFSE-labeled naïve OT-I and 
OT-II cells(CD44-, E-selectin ligand(E-lig)-, α4β7-, L-selectin(CD62L)+) into GF and SPF mice 24 
hours prior to OVA plus cholera toxin(CT) application and then evaluated different T cell homing 
markers(E-lig, α4β7, CD62L) at day 1, 3, 5, 7 after OVA+CT. In the experiment, we observed that 
OT-I cells proliferated more rapidly than OT-II cells in draining L/N at day 3 after OVA+CT(OT-I, > 
10 cell divisions; OT-II, 8 cell divisions) in both GF and SPF mice. Both OT-I and OT-II cells fully 
proliferated after day 5(> 10 cell divisions), but the proliferation of OT-I cells was stronger than that 
of OT-II cells in both mice. After the cells underwent division 5 times, the cells started to express 
E-lig and downregulate CD62L, but did not express α4β7. After 5 days, significant E-lig expression 
was observed in fully divided OT-I and OT-II cells, but OT-I cells expressed highly E-lig than OT-II 
cells in GF and SPF mice. We also observed significant number of OT-I(> 70% of total CD8+ T cells) 
and OT-II cells(~30% of total CD4+ T cells) recruited into the inflamed skin in both mice at day 
5, and then decreasing to a level of ~30% of total CD8+ T cells and ~10% of total CD4+ T cells, 
respectively, at day 7. During inflammatory state, more skin OT-I cells in GF mice were reduced 
compared with those in SPF mice, but the reduction of skin OT-II cells was not significantly different 
between these mice. Taken together, these results imply that skin resident commensals control the 
fine kinetic infiltration of skin homing T cells during inflammation.    
      
